|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61P 35/00 | (2006.01) | ||
| A61P 37/00 | (2006.01) |
| (11) | Number of the document | 2510010 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10794936.4 |
| Date of filing the European patent application | 2010-12-07 | |
| (97) | Date of publication of the European application | 2012-10-17 |
| (45) | Date of publication and mention of the grant of the patent | 2015-11-25 |
| (46) | Date of publication of the claims translation | 2016-02-10 |
| (86) | Number | PCT/EP2010/069090 |
| Date | 2010-12-07 |
| (87) | Number | WO 2011/070024 |
| Date | 2011-06-16 |
| (30) | Number | Date | Country code |
| 09015310 | 2009-12-10 | EP | |
| 10173407 | 2010-08-19 | EP |
| (72) |
DIMOUDIS, Nikolaos, DE
FERTIG, Georg, DE
FIDLER, Alexander, DE
KALUZA, Klaus, DE
THOMAS, Marlene, DE
RIES, Carola, DE
SEEBER, Stefan, DE
LANZENDOERFER, Martin, DE
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (74) |
Otilija KLIMAITIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Antikūnai, kurie rišasi prie žmogaus CSF1R ekstraląstelinio domeno 4, ir jų panaudojimas |
| Antibodies binding to human CSF1R extracellular domain 4 and their use |
| Payment date | Validity (years) | Amount | |
| 2024-11-21 | 15 | 289.00 EUR |
| 2025-12-07 |